AR058197A1 - Sal del compuesto de pleuromutilina como l- tartrato , hidrato no estequimetrico de la misma composicion farmaceutica que la comprende y su uso para preparar un medicamento - Google Patents
Sal del compuesto de pleuromutilina como l- tartrato , hidrato no estequimetrico de la misma composicion farmaceutica que la comprende y su uso para preparar un medicamentoInfo
- Publication number
- AR058197A1 AR058197A1 ARP060105067A ARP060105067A AR058197A1 AR 058197 A1 AR058197 A1 AR 058197A1 AR P060105067 A ARP060105067 A AR P060105067A AR P060105067 A ARP060105067 A AR P060105067A AR 058197 A1 AR058197 A1 AR 058197A1
- Authority
- AR
- Argentina
- Prior art keywords
- 2theta
- salt
- compound
- tartrate
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/66—Y being a hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sal del compuesto pleuromutilina que es el L-tartrato de trans-3-aminociclobutilo y (1S,2R,3S,4S,6R,7R,8R,14R)-4-etenil-3-hidroxi-2,4,7,14-tetrametil-9-oxotriciclo[5.4.3.01,8]tetradec-6-il imidodicarbonato (Compuesto 1A), en forma de estructura de estado solido. Sus solvatos, hidratos o mezclas e hidratos no estequiométricos con 2 a 7% de agua. La sal posee un patron de XRPD que tiene máximos característicos en las siguientes posiciones:6,7-+0,1 (°2theta), 10,0 -+0,1 (°2theta), 11,7+- 0,1(°2theta), 13,2 +- 0,1 (°2theta), 13,7 +- 0,1 (°2theta), 14,2 +- 0,1 (°2theta), 20,4 +- 0,1 (°2theta) y 23,5 +- 0,1 (°2theta). Composicion farmacéutica que la comprende y su uso para preparar un medicamento util para el tratamiento de infecciones respiratorias y de la piel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73830805P | 2005-11-18 | 2005-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058197A1 true AR058197A1 (es) | 2008-01-23 |
Family
ID=38068017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105067A AR058197A1 (es) | 2005-11-18 | 2006-11-17 | Sal del compuesto de pleuromutilina como l- tartrato , hidrato no estequimetrico de la misma composicion farmaceutica que la comprende y su uso para preparar un medicamento |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080269342A1 (es) |
EP (1) | EP1951671A4 (es) |
JP (1) | JP2009516704A (es) |
KR (1) | KR20080080125A (es) |
CN (1) | CN101360712A (es) |
AR (1) | AR058197A1 (es) |
AU (1) | AU2006318238A1 (es) |
BR (1) | BRPI0618775A2 (es) |
CA (1) | CA2630254A1 (es) |
CR (1) | CR9991A (es) |
EA (1) | EA200801364A1 (es) |
MA (1) | MA29950B1 (es) |
TW (1) | TW200736203A (es) |
WO (1) | WO2007062333A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2683684T3 (es) | 2011-03-08 | 2018-06-02 | ||
CN102813629A (zh) * | 2012-08-29 | 2012-12-12 | 湖北龙翔药业有限公司 | 一种酒石酸沃尼妙林预混剂的制备方法 |
CN103641702B (zh) * | 2013-11-18 | 2015-11-18 | 宁夏泰瑞制药股份有限公司 | 一种截短侧耳素的水解方法 |
TWI762573B (zh) | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
WO2018152408A1 (en) * | 2017-02-17 | 2018-08-23 | University Of Tennessee Research Foundation | Pleuromutilin derivatives and uses thereof |
CN111662220A (zh) * | 2020-04-20 | 2020-09-15 | 常州安蒂卫生物科技有限公司 | 用于治疗新型冠状病毒肺炎继发细菌感染性疾病的截短侧耳素类化合物 |
EP4338732A1 (en) | 2022-09-16 | 2024-03-20 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of tularemia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1182449A1 (en) * | 2000-08-21 | 2002-02-27 | Motorola, Inc. | Apparatus and method for managing an integrated circuit |
US20030219461A1 (en) * | 2000-09-12 | 2003-11-27 | Britten Nancy J. | Parenteral combination therapy for infective conditions |
GB0024811D0 (en) * | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
US6750064B2 (en) * | 2000-12-28 | 2004-06-15 | S.S.C.I. Inc. | Methods of screening for possible solid forms |
-
2006
- 2006-11-16 TW TW095142352A patent/TW200736203A/zh unknown
- 2006-11-17 AR ARP060105067A patent/AR058197A1/es unknown
- 2006-11-18 JP JP2008541495A patent/JP2009516704A/ja active Pending
- 2006-11-18 CA CA002630254A patent/CA2630254A1/en not_active Abandoned
- 2006-11-18 BR BRPI0618775-7A patent/BRPI0618775A2/pt not_active Application Discontinuation
- 2006-11-18 EP EP06839945A patent/EP1951671A4/en not_active Withdrawn
- 2006-11-18 US US12/093,729 patent/US20080269342A1/en not_active Abandoned
- 2006-11-18 CN CNA2006800513932A patent/CN101360712A/zh active Pending
- 2006-11-18 KR KR1020087014631A patent/KR20080080125A/ko not_active Application Discontinuation
- 2006-11-18 EA EA200801364A patent/EA200801364A1/ru unknown
- 2006-11-18 AU AU2006318238A patent/AU2006318238A1/en not_active Abandoned
- 2006-11-18 WO PCT/US2006/061066 patent/WO2007062333A2/en active Application Filing
-
2008
- 2008-05-15 MA MA30929A patent/MA29950B1/fr unknown
- 2008-05-20 CR CR9991A patent/CR9991A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101360712A (zh) | 2009-02-04 |
WO2007062333A3 (en) | 2007-11-08 |
TW200736203A (en) | 2007-10-01 |
AU2006318238A1 (en) | 2007-05-31 |
BRPI0618775A2 (pt) | 2011-09-13 |
WO2007062333A2 (en) | 2007-05-31 |
CR9991A (es) | 2008-07-29 |
MA29950B1 (fr) | 2008-11-03 |
EA200801364A1 (ru) | 2009-02-27 |
EP1951671A2 (en) | 2008-08-06 |
US20080269342A1 (en) | 2008-10-30 |
JP2009516704A (ja) | 2009-04-23 |
EP1951671A4 (en) | 2010-06-09 |
CA2630254A1 (en) | 2007-05-31 |
KR20080080125A (ko) | 2008-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058197A1 (es) | Sal del compuesto de pleuromutilina como l- tartrato , hidrato no estequimetrico de la misma composicion farmaceutica que la comprende y su uso para preparar un medicamento | |
CL2015003690A1 (es) | Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington. | |
AR051778A2 (es) | Derivados del acido dimetilaminocrotonico y procesos para supreparacion | |
GT201200126A (es) | Derivados de la cromenona con actividad anti-tumoral | |
AR069899A1 (es) | Compuestos quimicos derivados de pirazol-triazina | |
GT200500363A (es) | 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento. | |
AR099354A1 (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos | |
ECSP055899A (es) | Pirimidinas inhibidoras de chk, pdk y akt, su producción y su uso como agentes farmacéuticos | |
CL2007001996A1 (es) | Compuestos derivados de heteroarilos nitrogenados sustituidos con fenilo, inhibidores de la produccion de citoquinas; composicion farmaceutica que los comprende; y sus usos en el tratamiento del cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
AR062874A1 (es) | Composiciones farmaceuticas que contienen rosuvastatina calcio | |
CL2012001627A1 (es) | Compuestos derivados de 1,3-tiazol-fenilaminopirimidinas, inhibidores de syk; composición farmacéutica; y su uso para el tratamiento de la artritis reumatoide y cancer. | |
ECSP045491A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
CL2008001533A1 (es) | Formulacion que comprende triazinonas y compuestos o complejos ferricos, utiles para preparar medicamentos para uso veterinario contra la coccidiosis y deficiencias de hierro. | |
HN2000000115A (es) | Formulacion de sal comun y moxifloxacina | |
PA8638201A1 (es) | Forma cristalina alfa del ranelato de estroncio procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
UY29169A1 (es) | Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica | |
CL2003002611A1 (es) | Compuestos derivados del acido tiofeno hidroxamico, 2-hidroxamida-5-[(aril o heteroaril)-disutituido-metil]-amida del acido tiofeno-2,5-dicarboxilico enantiomeros, composicion farmaceutica, procedimiento de preparacion, y su uso para el tratamiento d | |
SV2006002290A (es) | Nonadepsipeptidos acilados ii ref. bhc041327-sv | |
PH12020551340A1 (en) | Methyllactam ring compound and pharmaceutical use thereof | |
CL2008003602A1 (es) | Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos. | |
PE20070825A1 (es) | Nuevo derivado de pleuromutilina y su uso | |
DOP2005000250A (es) | Amidas de acido pirazindicarboxilico y su uso | |
AR110913A1 (es) | Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |